Durability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (dpp–4i) in US Adults with Type 2 Diabetes
Diabetes Therapy（2023）
Key words
Comparative effectiveness,Dipeptidyl peptidase 4 inhibitor,Durability,Glucagon-like peptide 1 receptor agonist,Persistence,Semaglutide,Type 2 diabetes
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined